SFV HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Amgen Wins Otezla Patent Case

The U.S. District Court for New Jersey upheld patents that protect Otezla (apremilast), Amgen Inc.’s psoriasis treatment.

Lief Labs Signs Green Tea Partnership

Lief Raws, a division of Valencia-based dietary supplement manufacturer Lief Labs, has entered a licensing partnership that will enable it to be the distribution and sales arm for CellFlo6, a green tea extract.

Antelope Valley Hospital Dedicates Mental Health Unit to Deceased Doctor

Antelope Valley Hospital dedicated its mental health unit Tuesday in honor of Dr. John Beck, a longtime member of the hospital staff credited with starting the mental health unit in 1971.

Tease photo

Former Kythera CEO Joins Board of Arcutis Biotherapeutics

Keith Leonard Jr., the former chief executive of Kythera Biopharmaceuticals, has joined the board of Arcutis Biotherapeutics in Westlake Village.

Tease photo

LTC Pays for Smooth Transition Between Nursing Home Operators

LTC Properties Inc. has entered into a settlement agreement with two bankrupt former operators, Senior Care Centers and Abri Health Services, after receiving approval from a U.S. Bankruptcy Court.

Medolife Rx Reports Second Quarter Results

Biotech company Medolife Rx reported its second quarter financial and operational results.

Ventura County Issues Mask Mandate

Ventura County Public Health has issued a health order requiring individuals to wear face coverings while indoors in public settings, regardless of vaccination status.

Amgen to Require Vaccination for All Staff

Amgen Inc. will require that all employees be fully vaccinated against COVID-19 by Nov. 1, the Thousand Oaks company announced earlier this week.

Camarillo’s PBS Biotech Secures $10 Million in Funding Round

PBS Biotech has raised $10 million in a private funding round with investment bank BroadOak Capital Partners.

Second Sight Gets New Grant for Study

Sylmar-based Second Sight Medical Products, an implantable visual prosthetics developer, announced Wednesday that it received a $155,964 grant supplement from the National Institutes of Health.

Atara Biotherapeutics Reports Widening Loss, Adds Board Member

T-cell immunology company Atara Biotherapeutics Inc. reported its second-quarter 2021 financial results and the appointment of a cell therapy and oncology commercialization veteran to its board.

MannKind Partnership to Explore COVID Lung Treatment

Westlake Village biopharmaceutical company MannKind Corp. has entered a partnership with NRx pharmaceuticals to evaluate the feasibility of formulating a dry powder version of vasoactive intestinal peptide.

Medolife to Showcase Products at Tony Hawk Skateboard Competition

Quanta Inc. subsidiary Medolife Rx announced it will showcase its pain relief and immunapen product lines at 'Tony Hawk’s Vert Alert.'

Amgen Reports Revenue, Earnings Increase, But Shares Fall on Lower Guidance

Amgen Inc. beat expectations on revenue and earnings, but issued lower guidance for the rest of the year, sending shares lower.

Chinese Drug Agency Licenses Simulations Plus Software

Simulations Plus Inc. received an order from China’s drug evaluation agency to license its GastroPlus product.

Prev